Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sapana Shakya"'
Autor:
Rajindra Napit, Prajwol Manandhar, Ajit Poudel, Pragun G. Rajbhandari, Sarah Watson, Sapana Shakya, Saman M. Pradhan, Ajay N. Sharma, Ashok Chaudhary, Christine K. Johnson, Jonna K. Mazet, Dibesh Karmacharya
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Campylobacter spp. is often underreported and underrated bacteria that present real health risks to both humans and animals, including non-human primates. It is a commensal microorganism of gastrointestinal tract known to cause gastroenteritis in hum
Externí odkaz:
https://doaj.org/article/4ea1d31fc334417c873846a5089d0a0a
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background It is prudent that novel classes of antibiotics be urgently developed to manage the WHO prioritized multi-drug resistant (MDR) pathogens posing an unprecedented medical crisis. Simultaneously, multiple essential proteins have to b
Externí odkaz:
https://doaj.org/article/bc264175c21a4c6a91db0356407411ac
Additional file 3: Supplementary Table 3. 53 indole derivatives with higher B.E in MetK of Neisseria gonorrhoeae than SAM with their NNScore values.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b13a2fd2f5d5fdda6fbf6fd5af134e
Additional file 4: Supplementary Table 4. Docking results of two lead molecules in human homolog of MetK, Mat2B (RCSB id: 4KTT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d70e2bc1b63828c1238d5fb7e01027
Additional file 1: Supplementary Table 1. Putative lead target proteins identified as common, by whole genome sequence alignment of WHO priority list pathogens [3] and M. tuberculosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b53a599faceddd9fb7920c9813cd50
Autor:
Rajani Malla, Hari Datta Bhattarai, Suprim Tha, Pramod Aryal, Safalta Mallick, Sapana Shakya, Sita Ghimire
Background The rapid emergence of bacterial resistance and decreased efficacy of most antibiotics is a burning issue in the present medical world demanding swift development of novel classes of potent antibiotics. This study focuses on the robust ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd7a07fe3754baa90113bb290b74283
https://doi.org/10.21203/rs.2.17688/v1
https://doi.org/10.21203/rs.2.17688/v1